Metagenomi, Inc. (MGX)
(Delayed Data from NSDQ)
$2.10 USD
-0.13 (-5.83%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.10 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Metagenomi, Inc. has a market cap of $83.36M, which represents its share price of $2.23 multiplied by its outstanding shares number of 37.38M. As a small-cap company, MGX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MGX 2.10 -0.13(-5.83%)
Will MGX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MGX
BeOne Medicines Ltd. - Sponsored ADR (ONC) Surges 4.0%: Is This an Indication of Further Gains?
Metagenomi (MGX) Reports Q1 Loss, Misses Revenue Estimates
MGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
NewAmsterdam Pharma Company N.V. (NAMS) Reports Q1 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue Estimates
What Makes Metagenomi (MGX) a New Buy Stock
Other News for MGX
Sam Altman Says He 'Didn't Think' Elon Musk Would Abuse Government Power, Tesla CEO Hits Back With 'Scam Altman' Jibe
Oracle Surges with Strong Q4 Earnings and Promising Future Growth
OpenAI Looks To Raise $40 Billion From Global Investors Including Saudi Arabia's PIF, India's Reliance Industries To Accelerate AI Models And Stargate: Report
Metagenomi, Inc. Holds Annual Stockholders Meeting
Metagenomi, Inc. (MGX) Gets a Buy from H.C. Wainwright